<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alivizatos, G.</style></author><author><style face="normal" font="default" size="100%">Dimopoulos, A.</style></author><author><style face="normal" font="default" size="100%">Mitropoulos, D.</style></author><author><style face="normal" font="default" size="100%">Alevizou, K.</style></author><author><style face="normal" font="default" size="100%">Bougas, D.</style></author><author><style face="normal" font="default" size="100%">Pantazopoulos, D.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Efficacy of eight serially measured markers for diagnosis of prostatic carcinoma.</style></title><secondary-title><style face="normal" font="default" size="100%">Archivos Espanoles de Urologia</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">1992</style></year><pub-dates><date><style  face="normal" font="default" size="100%">1992</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026850289&amp;partnerID=40&amp;md5=61a2420d07f5fb8a3310a5105cd0d934</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">45</style></volume><pages><style face="normal" font="default" size="100%">269 - 272</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">In this study we measured eight different tumor markers (PSA, PAP, TPA, CEA, Ca 50, Ca 19-9, Ca 125 and Ca 15-3) in 39 patients with prostatic adenocarcinoma and in 90 patients with benign prostatic hyperplasia. We then calculated the sensitivity and specificity for each tumor marker separately and found that only PSA, when we consider as normal value 10 ng/ml, has a sufficiently high sensitivity and specificity. Our conclusion is that only PSA can be used for diagnostic purposes in conjunction with other diagnostic modalities.</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><notes><style face="normal" font="default" size="100%">Cited By :5Export Date: 21 February 2017</style></notes></record></records></xml>